Literature DB >> 29802957

Increased risk of respiratory diseases in adults with Type 1 and Type 2 diabetes.

Chelsey George1, Alan M Ducatman2, Baqiyyah N Conway3.   

Abstract

AIMS: Diabetes is linked with decreases in lung elasticity and in capacity to transfer carbon monoxide. Systemic inflammation, a common concern with diabetes, may contribute to airflow obstruction. We examined the association of self-reported diabetes with self-reported respiratory diseases (RDs) among 53,146 adults from the C8 Health Project.
METHODS: Participants were categorized into three groups: Type 1 (T1D, n = 781), Type 2 (T2D, n = 4277), or no diabetes (n = 48,088). ORs (95% CIs) for the association of diabetes with four RDs were computed: emphysema, chronic obstructive pulmonary disease (COPD), chronic bronchitis (CB), and asthma. Covariates controlled for were age, sex, estimated glomerular filtration rate, C-reactive protein, smoking history, BMI, and perfluorooctonaoic acid (C8).
RESULTS: RDs were present in 26%, 21% and 13% of persons with T1D, T2D, and no diabetes, respectively. In multivariable analyses, persons with T1D were 62% more likely to have any RD (OR: 1.62, CI: (1.36-1.93)), while those with T2D were 1.3 times as likely (OR: 1.26, CI: 1.15-1.37)). Compared to those without diabetes, in those with T1D and T2D diabetes respectively, ORs (CIs) for COPD were 1.89 (1.38-2.57), 1.45 (1.23-1.71), asthma: 1.51 (1.21-1.87), 1.38 (1.24-1.53), CB: 1.96 (1.57-2.45), 1.35 (1.20-1.52) and emphysema: 1.25 (0.85-1.82), 1.31 (1.10-1.56). Population attributable risks for any RDs associated with a history of smoking were 19%, 30%, and 26% for those with Type 1, Type 2, and no diabetes respectively.
CONCLUSIONS: Diabetes, more so in T1D, appears to increase RD risk. Smoking is an important risk factor, but not as informative in Type 1 diabetes.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29802957     DOI: 10.1016/j.diabres.2018.05.029

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

1.  Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin.

Authors:  Angelico Mendy; Radha Gopal; John F Alcorn; Erick Forno
Journal:  Respirology       Date:  2019-02-13       Impact factor: 6.424

2.  Sustained Hyperglycemia and Its Relationship with the Outcome of Hospitalized Patients with Severe COVID-19: Potential Role of ACE2 Upregulation.

Authors:  Jose R Vargas-Rodriguez; José J Valdés Aguayo; Idalia Garza-Veloz; Jacqueline Martinez-Rendon; Maria Del Refugio Rocha Pizaña; Griselda A Cabral-Pacheco; Vladimir Juárez-Alcalá; Margarita L Martinez-Fierro
Journal:  J Pers Med       Date:  2022-05-17

3.  Effect of Subcutaneous Insulin on Spirometric Maneuvers in Patients with Type 1 Diabetes: A Case-Control Study.

Authors:  Enric Sánchez; Chadia Mizab; Ariadna Sauret; Ferran Barbé; Raquel Martí; Carolina López-Cano; Marta Hernández; Liliana Gutiérrez-Carrasquilla; Paola Carmona; Jessica González; Mireia Dalmases; Cristina Hernández; Rafael Simó; Albert Lecube
Journal:  J Clin Med       Date:  2020-04-25       Impact factor: 4.241

4.  Impact of Comorbid Chronic Conditions to Quality of Life among Elderly Patients with Diabetes Mellitus in Vietnam.

Authors:  Huong Van Nguyen; Tung Thanh Tran; Cuong Tat Nguyen; Tung Hoang Tran; Bach Xuan Tran; Carl A Latkin; Cyrus S H Ho; Roger C M Ho
Journal:  Int J Environ Res Public Health       Date:  2019-02-13       Impact factor: 3.390

Review 5.  Mechanisms Linking COPD to Type 1 and 2 Diabetes Mellitus: Is There a Relationship between Diabetes and COPD?

Authors:  Sangmi S Park; Jessica L Perez Perez; Brais Perez Gandara; Christina W Agudelo; Romy Rodriguez Ortega; Huma Ahmed; Itsaso Garcia-Arcos; Cormac McCarthy; Patrick Geraghty
Journal:  Medicina (Kaunas)       Date:  2022-08-01       Impact factor: 2.948

6.  Diabetes and Mortality From Respiratory Diseases: The Japan Collaborative Cohort Study.

Authors:  Mengying Wang; Isao Muraki; Keyang Liu; Kokoro Shirai; Akiko Tamakoshi; Yonghua Hu; Hiroyasu Iso
Journal:  J Epidemiol       Date:  2019-12-14       Impact factor: 3.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.